Biosimilar Development Meetings At US FDA Not Just For Talking Similarity

 
• By Sue Sutter
Woman listens
US FDA is listening when biosimilar sponsors raise manufacturing and other issues during product development meetings.

More from Biosimilars

More from Biosimilars & Generics